Da Hee Han, PharmD

Most Recent Articles by Da Hee Han, PharmD

RECELL System Approved to Treat Severe Burns

By Sep 21, 2018

At Week 8 post-treatment, 92% of the burn sites treated with RECELL System achieved complete healing vs 85% of sites treated with standard-of-care, demonstrating non-inferiority.

FDA Issues Statement Addressing Safety Concerns Associated With Nuplazid

By Sep 21, 2018

Based on the data, the FDA has concluded that the drug's benefit continues to outweigh its risks for patients with hallucinations and delusions associated with Parkinson's disease psychosis.

Infant PPI Use and Lung Infection Risk: Is There a Link?

By Sep 20, 2018

The data showed matched odds ratio for current vs past use of PPIs to be 0.88 (95% CI, 0.36 to 2.16) when comparing cases and their controls for community-acquired pneumonia. With regard to lower respiratory tract infections, the matched odds ratio between cases and their controls was 1.13 (95% CI, 0.87 to 1.48).

FDA: Final Guidance on Heparin-Containing Devices, Combo Products

By Sep 19, 2018

The intent of the document is to help reduce heparin product overdose errors caused by misinterpretation of the drug strength displayed in the labeling.

ZTlido Patch for Post-Shingles Pain Launching Soon

By Sep 19, 2018

The non-aqueous adhesive patch requires 36mg per topical system to achieve the same therapeutic dose as Lidoderm (lidocaine 5%) which contains 700mg per patch.

More Articles by Da Hee Han, PharmD